Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Dimerix Bioscience Pty Limited
Sponsor

Dimerix Bioscience Pty Limited

425 Smith Street, 3065

About the sponsor

Dimerix Bioscience Pty Limited focuses on focal segmental glomerulosclerosis, a severe form of glomerular disease associated with progressive loss of kidney function.

  • Focal segmental glomerulosclerosis
  • Proteinuria
  • Estimated glomerular filtration rate

The sponsor’s active clinical work is centred on adult patients with persistent renal impairment and the preservation of kidney function in a nephrology setting.

About Specializations

Dimerix Bioscience Pty Limited runs clinical trials in conditions such as Focal segmental glomerulosclerosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Focal segmental glomerulosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Dimerix Bioscience Pty Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.